Results
1 -
10 of
71Drugu2013Drug Interactions Between the Anti-Hepatitis??C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers, Clinical Pharmacokinetics Hepatitis B and Hepatitis C Antiviral Agents, Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions Management of HCV Infection, Handbook of Hepatitis C Protease Inhibitor Resistance, Handbook of Antimicrobial Resistance Features of the Second Wave of the First Generation Protease Inhibitors: Effect and Tolerance, Hepatitis C Virus Treatment Emerging Antivirals in the Future, Hepatitis C Virus Treatment Aktuelle Arzneimitteltherapie der Hepatitis??C, Der Internist Therapie der Hepatitis??C, Der Internist Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient, European Journal of Clinical Pharmacology Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis, Journal of Gastroenterology